Navigation Links
Rochester Medical Announces Second Quarter 2013 Earnings Conference Call Thursday, April 25, 2013
Date:4/16/2013

STEWARTVILLE, Minn., April 16, 2013 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ: ROCM) will announce quarterly results after financial markets close on Thursday, April 25th, 2013.  The Company will then hold a quarterly conference call Thursday, April 25th, 2013 to discuss its earnings report.  The call will begin at 3:30 p.m., central time (4:30 p.m., Eastern Time).

(Logo: http://photos.prnewswire.com/prnh/20121228/CG34999LOGO)

This call is being webcast by Thomson Reuters and can be accessed at Rochester Medical's website at www.rocm.com.  To listen live to the conference call via telephone, call:Domestic: 

888 679 8018International:

617 213 4845Pass code:

69140545Pre Registration:
https://www.theconferencingservice.com/prereg/key.process?key=PFY3WDB6CReplay will be available for seven days at www.rocm.com or via telephone at:Domestic:

888 286.8010International:

617 801.6888Pass code:

48212906Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway , President and Chief Executive Officer or David A. Jonas , Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600.  More information about Rochester Medical is available on its website at '/>"/>

SOURCE Rochester Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rochester Medical Corporation to Participate in The Benchmark Company, LLC Micro Cap Discovery Conference
2. Rochester Medical Corporation to Participate in the 24th Annual Piper Jaffray Healthcare Conference
3. Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results
4. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
5. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
6. Rochester Medical Reports Third Quarter Results
7. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
8. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
9. Span-America Medical Systems To Release Second Quarter Results On May 1, 2013
10. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
11. Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Following a bipartisan ... that moved H.R. 284, the Medicare DMEPOS Competitive ... Association for Homecare (AAHomecare) released a statement praising ... to pass the legislation. "Today,s mark-up ... House Ways and Means Committee is a critical ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)...   Synageva BioPharma Corp. (Synageva) (NASDAQ: ... therapeutic products for rare diseases, joins the National ... for Rare Diseases™ (EURORDIS™), The Global Genes Project™, ... Disease Day. On the last day ... other participants conduct special events to raise awareness ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... with investigators worldwide to develop new treatments for ... diverse forms of cancer - Plenary ... of patients with early-stage breast cancer, - Four oral sessions to feature ... study in renal cell ...
... Hispanics/Latinos, People ... with Diabetes and Obese Individuals, PARSIPPANY, N.J., ... presented at the American Society of,Hypertension,s Twenty- Third Annual ... powerful combination drug AZOR(TM),(amlodipine and olmesartan medoxomil) safely and ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as part ... the latest and coolest technology products and services available to ... technology expert, conducted the review and shared with viewers how ... stuck with a low battery and no way to charge ... on a daily basis. Even when a person does have ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous announcement ... reader named Guardian 2. The correct product name ... scanner that significantly increases the complexity of security ... scanner provides fast and easy access for both ... lockers with Vanguard technology tracks inventory by ...
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... 27, 2015 Hispanics develop alcoholic liver ... four and 12 years earlier than Whites/Caucasians or African ... Health System. , While previous research indicated that Hispanics ... the new study -- published online in the journal ... be the first to pinpoint racial and ethnic disparities ...
(Date:2/27/2015)... OnChip Devices , a world leader ... bondable, silicon ESD (Electrostatic Discharge) protection diodes targeted for ... ESD88NP and ESD88PN are designed to ... IC products. These Zeners exhibit no device degradation ... meet the requirements of IEC61000 and safely dissipate ESD ...
Breaking Medicine News(10 mins):Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
... time , , TUESDAY, Jan. 15 (HealthDay News) -- Foodborne illness can ... different pathogens. Here is a rundown of the most common bacterial ... E. COLI 0157:H7 , There are many strains ... coli. Most are harmless, four or five can cause disease, and ...
... drinks containing live bacteria, have a tangible effect on the ... today (Tuesday 15 January) in the journal Molecular Systems Biology. ... at how probiotics change the biochemistry of bugs known as ... an important part in a persons metabolic makeup. Different people ...
... Integrated Solutions Help Dearborn County Hospital Better Serve ... Area with Heightened Productivity and Collaboration, ... Dearborn County Hospital,in southeast Indiana, efficient yet responsive ... patients and patient,families. To boost care levels even ...
... Postmenopausal women who take combined estrogen/progestin hormone-replacement ... fourfold increased risk of developing various forms of ... researchers at Fred Hutchinson Cancer Research Center., Previous ... combined hormone-therapy use was necessary to increase overall ...
... feedback feature promotes a more informed health care ... and regional studies,indicate that informed patients make better ... is launching a member feedback feature in,Spring 2008 ... to share,information with each other about their provider ...
... Rivers,Pharmaceuticals, LLC finalized acquisition of the hepatitis C ... ). Valeant is,receiving $91 million from Three Rivers ... growing portfolio is very exciting," said,Donald J. Kerrish, ... purchase is only a beginning for Three Rivers, ...
Cached Medicine News:Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 2Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 3Health News:U.S. Food Safety: Foodborne Illnesses a Menu for Disaster 4Health News:Probiotics affect metabolism, says new study 2Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 2Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 3Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 4Health News:Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions 5Health News:Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use 2Health News:Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options 2Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism....
... offers patient monitoring products for hospital ... medium acuity monitoring. The Envoy patient ... The Enmove monitor offers a ... complement the Envoy. The Ensemble ...
... The Mayfield Triad Skull Clamp, compatible with ... visual indication of clamping force on all ... user with the possibility of adjusting the ... can easily be increased or decreased by ...
Protein-to-creatinine ratio is key to earlier detection of Kidney Disease...
Medicine Products: